Kymera Therapeutics (KYMR US)

Kymera Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. Kymera Therapeutics serves customers in the State of Massachusetts.